First Page | Meta Content | |
---|---|---|
Document Date: 2014-11-18 22:42:22Open Document File Size: 869,00 KBShare Result on FacebookCityMelbourne / Sydney / /CompanyNSW Therapeutic Advisory Group / Therapeutic Guidelines Ltd / Improving / Australian Medicines Handbook Pty Ltd / Duke AB / National Prescribing Service Limited / The Discharge Management / /CountryAustralia / /IndustryTermaudit tool / appropriate medication management / data collection tool / quality improvement tool / appropriate ongoing medication management / prevention of coronary heart disease / appropriate management / /MedicalConditionacute coronary syndromes / Other Atherosclerotic Vascular Disease / Stroke / Heart Disease / allergy / acute coronary syndrome / coronary syndrome / Unstable angina pectoris / left ventricular systolic dysfunction / Coronary Heart Disease / ST-segment-elevation myocardial infarction / Acute Myocardial Infarction / /MedicalTreatmentpharmacotherapy / /NaturalFeatureRoe MT / /OrganizationNational Park Service / Cardiac Society of Australia and New Zealand / Clinical Excellence Commission / Australia/Cardiac Society of Australia and New Zealand Guidelines for the Management of Acute Coronary Syndromes / Australian Commission on Safety and Quality / European Society of Cardiology / Pharmaceutical Advisory Council / National Heart Foundation / Victorian Government Department of Human Services / /PositionGovernor / General / /ProductSafe Medication / telmisartan / ramipril / valsartan / irbesartan / lisinopril / simvastatin / quinapril / clopidogrel / captopril / trandolapril / carvedilol / atenolol / losartan / /ProvinceOrStateQueensland / Oregon / Connecticut / /URLwww.nps.org.au/health-professionals/cpd/activities/due-for-hospitals/discharge-management-of-acute-coronary-syndromes/dmacs-due/_ / www.cec.health.nsw.gov.au_ / /SocialTag |